Cambridge’s new Affordable Housing Overlay has had a tremendous and immediate effect on parcels already in nonprofit hands, adding over 400 new units of affordable housing to the pipeline in a year and a half.
Boston developer Cabot, Cabot & Forbes has filed plans with Cambridge officials for a 58,000-square-foot research and development building near the site of a major planned biotech development in the city’s west.
With more than $1.9 billion in West Cambridge acquisitions since 2019, the Denver-based REIT Healthpeak Properties is poised to begin testing the city’s appetite for a second Kendall Square-like cluster.
Vor Biopharma will expand at 100 Cambridgepark Drive with the construction of an in-house clinical manufacturing facility, growing its footprint to 75,000 square feet on three floors.
Life science developer IQHQ proposes three new R&D buildings at its recently-acquired campus in Cambridge’s Alewife section.
A large apartment complex in Cambridge’s Alewife neighborhood is one step closer to starting construction after developer Toll Brothers announced it had secured a construction loan and a development partnership for the project.
The Davis Cos. is set to break ground on the next 155,000-square-foot phase of its Quad campus in early 2021 after attracting South Boston-based Gingko Bioworks to the West Cambridge portfolio.
King Street Properties and Healthpeak have begun construction of a new 160,000-square-foot life science building on Cambridgepark Drive.
The land rush at Cambridge’s final development frontier shows no sign of abating, and city officials hope to leverage private investment into public benefits including new transit connections and park space.
A slew of covered land plays in recent weeks, from Widette Circle to Alewife, are giving investors a ready stream of rent while they assess the impact of COVID-19 on real estate and plan their next moves in growing development clusters.
Construction materials manufacturer GCP Applied Technologies has agreed to sell its 26-acre headquarters property in Cambridge to IQHQ Inc., a life science REIT.
A Cambridge construction materials manufacturer will occupy its 290,000-square-foot headquarters rent-free for 18 months after the pending sale of the property for $125 million to a life science developer.
Two months after a six-building, 1 million-square-foot multifamily and lab complex was pitched for Cambridge’s Alewife Quadrangle neighborhood, another developer is joining the effort to revamp the industrial area near Belmont
East Cambridge maintained its position as the region’s top destination for lab tenants, with asking rents topping $101 per square foot triple-net in the fourth quarter.
Greater Boston’s booming real estate industry continues to reshape the local landscape as the real estate cycle passes the decade mark, and 2020 is likely to generate more headlines about how developers are responding to the region’s job growth and housing needs.
From a booming life science industry spreading further out from East Cambridge to new multifamily housing models and an e-commerce-fueled explosion in interest in distribution facilities, here’s what drove demand in 2019.
The Hanover Cos. of Houston has sold its 88 Cambridgepark Drive apartment complex to Guardian Life Insurance Co. for $150 million.
A California real estate investor has completed its $332.5 million acquisition of Alewife Research Center, a speculative development that attracted five life science companies to West Cambridge’s growing lab cluster.
Housing developer Toll Brothers has paid $44.1 million to acquire a site approved for a 525-unit apartment complex in Cambridge’s Quadrangle neighborhood.
Now that Wall Street investors have discovered the Alewife neighborhood and its fast-growing life science cluster, change seems inevitable and Cambridge officials have completed a playbook designed to shape future development.
